270 related articles for article (PubMed ID: 17635799)
1. Autoimmune prostatitis: state of the art.
Motrich RD; Maccioni M; Riera CM; Rivero VE
Scand J Immunol; 2007; 66(2-3):217-27. PubMed ID: 17635799
[TBL] [Abstract][Full Text] [Related]
2. Reduced semen quality in chronic prostatitis patients that have cellular autoimmune response to prostate antigens.
Motrich RD; Maccioni M; Molina R; Tissera A; Olmedo J; Riera CM; Rivero VE
Hum Reprod; 2005 Sep; 20(9):2567-72. PubMed ID: 15890732
[TBL] [Abstract][Full Text] [Related]
3. HDAC inhibitor MS-275 attenuates the inflammatory reaction in rat experimental autoimmune prostatitis.
Zhang ZY; Schluesener HJ
Prostate; 2012 Jan; 72(1):90-9. PubMed ID: 21538420
[TBL] [Abstract][Full Text] [Related]
4. Sphingosine 1-phosphate receptor modulator FTY720 suppresses rat experimental autoimmune prostatitis.
Zhang ZY; Zug C; Schluesener HJ
Scand J Immunol; 2011 Jun; 73(6):546-53. PubMed ID: 21323692
[TBL] [Abstract][Full Text] [Related]
5. Non-obese diabetic (NOD) mice are genetically susceptible to experimental autoimmune prostatitis (EAP).
Rivero VE; Cailleau C; Depiante-Depaoli M; Riera CM; Carnaud C
J Autoimmun; 1998 Dec; 11(6):603-10. PubMed ID: 9878082
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune etiology in chronic prostatitis syndrome: an advance in the understanding of this pathology.
Rivero VE; Motrich RD; Maccioni M; Riera CM
Crit Rev Immunol; 2007; 27(1):33-46. PubMed ID: 17430095
[TBL] [Abstract][Full Text] [Related]
7. Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia.
Penna G; Mondaini N; Amuchastegui S; Degli Innocenti S; Carini M; Giubilei G; Fibbi B; Colli E; Maggi M; Adorini L
Eur Urol; 2007 Feb; 51(2):524-33; discussion 533. PubMed ID: 16905241
[TBL] [Abstract][Full Text] [Related]
8. Effect of alcohol on chronic pelvic pain and prostatic inflammation in a mouse model of experimental autoimmune prostatitis.
Zhang LG; Chen J; Meng JL; Zhang Y; Liu Y; Zhan CS; Chen XG; Zhang L; Liang CZ
Prostate; 2019 Sep; 79(12):1439-1449. PubMed ID: 31233226
[TBL] [Abstract][Full Text] [Related]
9. Crucial role of interferon-gamma in experimental autoimmune prostatitis.
Motrich RD; van Etten E; Baeke F; Riera CM; Mathieu C; Rivero VE
J Urol; 2010 Mar; 183(3):1213-20. PubMed ID: 20096883
[TBL] [Abstract][Full Text] [Related]
10. Chronic Pelvic Pain Development and Prostate Inflammation in Strains of Mice With Different Susceptibility to Experimental Autoimmune Prostatitis.
Breser ML; Motrich RD; Sanchez LR; Rivero VE
Prostate; 2017 Jan; 77(1):94-104. PubMed ID: 27699823
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer induction in autoimmune rats and modulation of T cell apoptosis.
Gilardoni MB; Rabinovich GA; Oviedo M; Depiante-Depaoli M
J Exp Clin Cancer Res; 1999 Dec; 18(4):493-504. PubMed ID: 10746976
[TBL] [Abstract][Full Text] [Related]
12. Expression of CXCR3 on specific T cells is essential for homing to the prostate gland in an experimental model of chronic prostatitis/chronic pelvic pain syndrome.
Breser ML; Motrich RD; Sanchez LR; Mackern-Oberti JP; Rivero VE
J Immunol; 2013 Apr; 190(7):3121-33. PubMed ID: 23455510
[TBL] [Abstract][Full Text] [Related]
13. Impact of vitamin D receptor activity on experimental autoimmune prostatitis.
Motrich RD; van Etten E; Depovere J; Riera CM; Rivero VE; Mathieu C
J Autoimmun; 2009 Mar; 32(2):140-8. PubMed ID: 19269787
[TBL] [Abstract][Full Text] [Related]
14. Prostate autoimmunity: from experimental models to clinical counterparts.
Penna G; Fibbi B; Maggi M; Adorini L
Expert Rev Clin Immunol; 2009 Sep; 5(5):577-86. PubMed ID: 20477643
[TBL] [Abstract][Full Text] [Related]
15. Experimental rodent models of prostatitis: limitations and potential.
Vykhovanets EV; Resnick MI; MacLennan GT; Gupta S
Prostate Cancer Prostatic Dis; 2007; 10(1):15-29. PubMed ID: 17199136
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune prostatitis: evidence of T cell reactivity with normal prostatic proteins.
Alexander RB; Brady F; Ponniah S
Urology; 1997 Dec; 50(6):893-9. PubMed ID: 9426720
[TBL] [Abstract][Full Text] [Related]
17. Experimental autoimmune prostatitis: different antigens induction and antigen-specific therapy.
Liu Y; Wazir J; Tang M; Ullah R; Chen Y; Chen T; Zhou X
Int Urol Nephrol; 2021 Apr; 53(4):607-618. PubMed ID: 33200334
[TBL] [Abstract][Full Text] [Related]
18. Identification of rat prostatic steroid-binding protein as a target antigen of experimental autoimmune prostatitis: implications for prostate cancer therapy.
Liu KJ; Chatta GS; Twardzik DR; Vedvick TS; True LD; Spies AG; Cheever MA
J Immunol; 1997 Jul; 159(1):472-80. PubMed ID: 9200488
[TBL] [Abstract][Full Text] [Related]
19. TRPV1 in experimental autoimmune prostatitis.
Roman K; Hall C; Schaeffer AJ; Thumbikat P
Prostate; 2020 Jan; 80(1):28-37. PubMed ID: 31573117
[TBL] [Abstract][Full Text] [Related]
20. Activated autophagy restored the impaired frequency and function of regulatory T cells in chronic prostatitis.
Liu Y; Zhang Y; Zhang M; Meng J; Ma Q; Hao Z; Zheng M; Zhang L; Chen X; Liang C
Prostate; 2021 Jan; 81(1):29-40. PubMed ID: 33085775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
